ZHANG Qiping - Net Worth and Insider Trading
ZHANG Qiping Net Worth
The estimated net worth of ZHANG Qiping is at least $557 Million dollars as of 2024-12-26. ZHANG Qiping is the 2201 Interest of corporation controlled by you of Ocumension Therapeutics and owns about 126,200,000 shares of Ocumension Therapeutics (HKSE:01477) stock worth over $557 Million. Details can be seen in ZHANG Qiping's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that ZHANG Qiping has not made any transactions after 2024-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of ZHANG Qiping
ZHANG Qiping Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, ZHANG Qiping owns 1 companies in total, including Ocumension Therapeutics (HKSE:01477) .
Click here to see the complete history of ZHANG Qiping’s form 4 insider trades.
Insider Ownership Summary of ZHANG Qiping
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01477 | Ocumension Therapeutics | 2024-11-15 | 2201 Interest of corporation controlled by you |
ZHANG Qiping Latest Holdings Summary
ZHANG Qiping currently owns a total of 1 stock. ZHANG Qiping owns 126,200,000 shares of Ocumension Therapeutics (HKSE:01477) as of October 16, 2024, with a value of $557 Million.
Latest Holdings of ZHANG Qiping
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01477 | Ocumension Therapeutics | 2024-10-16 | 126,200,000 | 4.41 | 556,542,000 |
Holding Weightings of ZHANG Qiping
ZHANG Qiping Form 4 Trading Tracker
According to the SEC Form 4 filings, ZHANG Qiping has made a total of 1 transactions in Ocumension Therapeutics (HKSE:01477) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Ocumension Therapeutics is the sale of 0 shares on October 16, 2024, which brought ZHANG Qiping around $0.
Insider Trading History of ZHANG Qiping
- 1
ZHANG Qiping Trading Performance
ZHANG Qiping Ownership Network
ZHANG Qiping Owned Company Details
What does Ocumension Therapeutics do?
Who are the key executives at Ocumension Therapeutics?
ZHANG Qiping is the 2201 Interest of corporation controlled by you of Ocumension Therapeutics. Other key executives at Ocumension Therapeutics include 2201 Interest of corporation controlled by you 6 Dimensions Capital GP, LLC , 2101 Beneficial owner 6 Dimensions Capital, L.P. , and 2201 Interest of corporation controlled by you su zhou fu yan chuang ye tou zi guan li he huo qi ye you xian he huo .
Ocumension Therapeutics (HKSE:01477) Insider Trades Summary
Over the past 18 months, ZHANG Qiping made 1 insider transaction in Ocumension Therapeutics (HKSE:01477) with a net sale of 0. Other recent insider transactions involving Ocumension Therapeutics (HKSE:01477) include a net sale of 0 shares made by Liu Ye , a net sale of 3,800,000 shares made by Temasek Holdings (private) Limited , and a net purchase of 150,000 shares made by Boyu Capital Group Holdings Ltd .
In summary, during the past 3 months, insiders sold 0 shares of Ocumension Therapeutics (HKSE:01477) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,227,000 shares of Ocumension Therapeutics (HKSE:01477) were sold and 150,000 shares were bought by its insiders, resulting in a net sale of 4,077,000 shares.
Ocumension Therapeutics (HKSE:01477)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocumension Therapeutics Insider Transactions
ZHANG Qiping Mailing Address
Above is the net worth, insider trading, and ownership report for ZHANG Qiping. Currently GuruFocus does not have mailing address information for ZHANG Qiping.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
